| Product Number : |
CL1889 |
| Product Name : |
DMXAA |
| CAS No. : |
117570-53-3 |
| Synonyms : |
(ASA-404; Vadimezan;NSC 640488); 5,6-Dimethylxantheonone-4-acetic acid |
| Chemical Name : |
|
| Molecular Formula : |
C17H14O4 |
| Molecular Weight : |
282.29 |
| Molecular Structure : |
 |
| Appearance : |
Light brown powder |
| Specification : |
98+% |
| Application : |
|
| Registration : |
|
| Storage Condition : |
Vadimezan, also known as DMXAA and ASA404, is a fused tricyclic analogue of flavone acetic acid with potential antineoplastic activity. Vadimezan induces the cytokines tumor necrosis alpha (TNF-alpha), serotonin and nitric oxide, resulting in hemorrhagic necrosis and a decrease in angiogenesis. This agent also stimulates the anti-tumor activity of tumor-associated macrophages.
Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.
